Taho Pharmaceuticals Ltd.

NT$235.00As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6467Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (60.29%)
Pharmaceutical Preparations
Beta (5Y) (0.74)
PE TTM —
TSR TTM 47.34%
Mkt cap NT$12.32B
ROIC (37.29%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$300
27.63%
(87.61%)
Hold 8|10|9|0|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
3.72
3.60
3.90
4.12
30.66%
19.56%
15.72%
21.85%
RevenueNT$M
888.8
931.9
962.9
935.6
9.41%
10.56%
9.73%
8.99%
Peers (US$372.8M)
Cap (US$)
PE
374.4M
81.01x
Capital
TTM
5Y
10Y
Leveragex
0.611
—
—
EBIT/Intx
2.100
0.098
0.106
Own earn%
(28.89)
179.20
163.82
Sh yield%
29.97
51.45
48.55
Owners
Insiders/Inst%
12.96
69.27
Short interest%
3.22
SBC / revenue%
4.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
0–10
$1 testx
0.0
Incr. ROIC%
30